Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Weekly shot aims to protect hemophilia Patients' joints

NCT ID NCT06941870

Summary

This study is testing whether a weekly preventative treatment called efanesoctocog alfa can reduce harmful swelling in the joints of people with hemophilia A. About 35 participants with existing joint swelling will receive the weekly treatment for 12 months. Doctors will use ultrasound scans to see if the treatment improves the health of their elbows, knees, and ankles.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FACTOR VIII DEFICIENCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Innovative Hematology, Inc.- Site Number : 8400006

    RECRUITING

    Indianapolis, Indiana, 46260, United States

  • Investigational Site Number : 1240003

    RECRUITING

    Hamilton, Ontario, L8N 3Z5, Canada

  • Investigational Site Number : 1240004

    RECRUITING

    Hamilton, Ontario, L8N 3Z5, Canada

  • Investigational Site Number : 1580001

    RECRUITING

    Taichung, 407, Taiwan

  • Investigational Site Number : 1580002

    RECRUITING

    Taipei, 114, Taiwan

  • Investigational Site Number : 1580003

    RECRUITING

    Kaohsiung City, 80756, Taiwan

  • Investigational Site Number : 3920001

    RECRUITING

    Saitama, 330-8777, Japan

  • Investigational Site Number : 3920002

    RECRUITING

    Hiroshima, 734-8551, Japan

  • Investigational Site Number : 3920003

    RECRUITING

    Kawasaki, Kanagawa, 216-8511, Japan

  • Investigational Site Number : 3920004

    RECRUITING

    Tokyo, 160-0023, Japan

  • Ohio State University Hospital East- Site Number : 8400001

    RECRUITING

    Columbus, Ohio, 43203-1779, United States

  • Orthopedic Institute for Children- Site Number : 8400009

    RECRUITING

    Los Angeles, California, 90007, United States

  • University of Iowa- Site Number : 8400004

    RECRUITING

    Iowa City, Iowa, 52242, United States

Conditions

Explore the condition pages connected to this study.